Taro Pharmaceutical Industries (FRA:TAL) 5-Year Yield-on-Cost % : 0.00 (As of May. 17, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Taro Pharmaceutical Industries 5-Year Yield-on-Cost %?

Taro Pharmaceutical Industries's yield on cost for the quarter that ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Taro Pharmaceutical Industries's 5-Year Yield-on-Cost % or its related term are showing as below:

FRA:TAL's 5-Year Yield-on-Cost % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.08
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Taro Pharmaceutical Industries's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Taro Pharmaceutical Industries's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Taro Pharmaceutical Industries's 5-Year Yield-on-Cost % falls into.

Taro Pharmaceutical Industries 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Taro Pharmaceutical Industries is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Taro Pharmaceutical Industries (FRA:TAL) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Taro Pharmaceutical Industries 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Taro Pharmaceutical Industries (FRA:TAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (FRA:TAL) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

TARO:USA

Address

14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761

Website

https://www.taro.com

Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.